Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2026The Hastings Center ReportOpen Access

Transformed but Not Cured: The Ethics of Describing Gene‐Editing Therapy for Sickle Cell Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJada Wiggleton-LittleSTShameka Poetry ThomasKWKristin Walters

Discussion

Loading...

Member takes

Overview

Essay explores risks of labeling gene-editing therapy as a cure for sickle cell disease, highlighting ethical concerns and communication gaps.

Key Points

  • The aim is to discuss the ethical implications of describing gene-editing therapies as cures for sickle cell disease, especially regarding the non-transformation of all SCD aspects.
  • Analysis of FDA approval of gene-editing therapies for sickle cell disease
  • Discussion of the limitations of gene editing in addressing all symptoms of SCD
  • Examination of the impact of curative language on patient-provider interactions.
  • Gene editing may normalize hematologic function but does not address all aspects of sickle cell disease.
  • Using 'cure' can create false expectations and misunderstandings in patient communication.
  • There is a call for bioethical awareness regarding the language used in describing gene editing therapies.

Cite This Study

Wiggleton-Little et al. (2026) studied this question.

synapsesocial.com/papers/69fd7e79bfa21ec5bbf06a5bhttps://doi.org/10.1002/hast.70033
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chain Reactions: Assessing the Potential for Heritable DNA Modification to Create Generational Benefits for Communities Affected by Sickle Cell Disease2024
  2. 2Current state of gene therapy in sickle cell disease2024 · 14 citations
  3. 3The Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care2026
  4. 4Gene Therapy for Sickle Cell Disease: No Donor, No Problem2025
  5. 5Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches2025 · 16 citations